Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

GlycoMimetics Inc (NASDAQ:GLYC)

5.73
Delayed Data
As of Jan 20
 -0.05 / -0.87%
Today’s Change
3.70
Today|||52-Week Range
9.25
-6.07%
Year-to-Date
No recent news for GlycoMimetics Inc.

Today’s Trading

Previous close5.78
Today’s open5.74
Day’s range5.61 - 5.93
Volume24,088
Average volume (3 months)51,314
Market cap$132.2M
Dividend yield--
Data as of 4:00pm ET, 01/20/2017

Growth & Valuation

Earnings growth (last year)-11.67%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)+33.56%
P/E ratioNM
Price/Sales5.42
Price/Book2.70

Competitors

 Today’s
change
Today’s
% change
KURAKura Oncology Inc-0.15-2.38%
REPHRecro Pharma Inc-0.01-0.14%
MRTXMirati Therapeutics ...-0.20-3.67%
SNDXSyndax Pharmaceutica...-0.09-1.27%
Data as of 4:00pm ET, 01/20/2017

Financials

Next reporting dateMarch 20, 2017
EPS forecast (this quarter)-$0.38
Annual revenue (last year)$20.1M
Annual profit (last year)-$12.8M
Net profit margin-63.62%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Rachel K. King
Chief Financial Officer
Brian M. Hahn
Corporate headquarters
Rockville, Maryland

Forecasts


Search for Jobs